|
Market Closed -
Nasdaq
08:00:00 21/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 920.69 USD | -0.19% |
|
-3.64% | +19.28% |
| 20/11 | Argus Adjusts Price Target on Regeneron Pharmaceuticals to $1,050 From $850 | MT |
| 20/11 | New Transactions in US Portfolio |
| Market Cap | 92.39B 84.15B 77.54B 70.53B 132B 8,555B 139B 944B 375B 4,673B 347B 339B 14,665B | P/E 2026 * |
15.5x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 85.22B 77.62B 71.52B 65.06B 122B 7,892B 128B 870B 346B 4,310B 320B 313B 13,527B | EV / Sales 2026 * |
4.53x | EV / Sales 2027 * | 3.96x |
| Free-Float |
72.51% | Yield 2026 * |
0.41% | Yield 2027 * | 0.44% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| REGN | Delayed | |
| REGN | Real-time | ||
| RGO | Real-time | ||
| REGN * | End-of-day quote | ||
| RGO | Real-time | ||
| RGO | End-of-day quote | ||
| 0R2M | Delayed | ||
| RGO | Delayed | ||
| 1REGN | End-of-day quote | ||
| REGN | End-of-day quote | ||
| RGO | Delayed | ||
| REGNUS | End-of-day quote |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.19% | ||
| 1 week | -3.64% | ||
| Current month | -0.78% | ||
| 1 month | +14.28% | ||
| 3 months | +10.39% | ||
| 6 months | +43.28% | ||
| Current year | +19.28% |
| 1 week | 916.66 | 972.24 | |
| 1 month | 796.61 | 991.73 | |
| Current year | 591.52 | 991.73 | |
| 1 year | 591.52 | 991.73 | |
| 3 years | 476.49 | 1,211.2 | |
| 5 years | 476.49 | 1,211.2 | |
| 10 years | 271.37 | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 01/01/2001 | |
| Chief Executive Officer | 73 | 08/01/1988 | |
| Director of Finance/CFO | 55 | 05/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 09/06/2023 | |
Joseph Goldstein
BRD | Director/Board Member | 85 | 01/06/1991 |
George Sing
BRD | Director/Board Member | 76 | 08/01/1988 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/26 | Exercice | SVP Controller | 11,828 | 0.0117% | ||
| 3/11/26 | Exercice | Director | 22,317 | 0.0221% | ||
| 3/11/26 | Don | Chief Technology Officer | -1,054 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.19% | -3.64% | +21.80% | +15.25% | 92.39B | ||
| -0.30% | -6.68% | +27.12% | +127.32% | 1,200B | ||
| +1.25% | -5.35% | +32.65% | +78.98% | 651B | ||
| +0.94% | -2.99% | +21.13% | +106.30% | 506B | ||
| -0.60% | -1.95% | +25.73% | +67.00% | 377B | ||
| +0.69% | -9.50% | +36.78% | +30.83% | 330B | ||
| +0.41% | -4.70% | +24.18% | +50.18% | 288B | ||
| +0.81% | -4.08% | -2.95% | +31.59% | 272B | ||
| -0.15% | -6.45% | +29.06% | +65.76% | 236B | ||
| -0.06% | -0.98% | +31.42% | +122.83% | 206B | ||
| Average | +0.28% | -4.64% | +24.69% | +69.60% | 416B | |
| Weighted average by Cap. | +0.29% | -5.16% | +25.93% | +86.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.81B 17.14B 15.79B 14.36B 26.95B 1,742B 28.32B 192B 76.38B 952B 70.59B 69.1B 2,987B | 20.17B 18.37B 16.93B 15.4B 28.88B 1,867B 30.36B 206B 81.87B 1,020B 75.67B 74.07B 3,201B |
| Net income | 6.43B 5.85B 5.39B 4.91B 9.2B 595B 9.67B 65.64B 26.09B 325B 24.11B 23.6B 1,020B | 6.56B 5.97B 5.51B 5.01B 9.39B 607B 9.87B 67B 26.63B 332B 24.61B 24.09B 1,041B |
| Net Debt | -7.17B -6.53B -6.02B -5.47B -10.27B -664B -10.79B -73.22B -29.1B -363B -26.89B -26.33B -1,138B | -12.52B -11.4B -10.51B -9.56B -17.93B -1,159B -18.84B -128B -50.82B -633B -46.96B -45.97B -1,987B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/11/26 | USD 920.69 | -0.29% | 878,261 |
| 19/11/26 | USD 923.34 | -2.35% | 723,486 |
| 18/11/26 | USD 945.53 | -1.28% | 705,406 |
| 17/11/26 | USD 957.76 | +0.56% | 933,408 |
| 16/11/26 | USD 952.40 | -0.32% | 700,861 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions

















